1. Langen, P. (1975)Antimetabolites of Nucleic Acid Metabolism, Gordon and Bresch, New York, London and Paris
2. Ferber, E., Körner, E., Schmidt, B., Peskar, B.A., and Anders, C. (1980) inMembrane Fluidity: Biophysical Techniques and Cellular Regulation, Part IV: Phospholipid Changes Accompanying Physiological Events, (Kates, M., and Kuksis, A., eds.) pp. 239–263, The Human Press, Inc., Clifton, NJ.
3. Nishizuka, Y. (1984)Science 225, 1365–1370.
4. Munder, P.G., Modolell, M., Bausert, W., Oettgen, H.F., and Westphal, O. (1981) inAugmenting Agents in Cancer Therapy, (Hersh, E.M., ed.) pp. 441–467, Raven Press, New York.
5. Berdel, W.E. (1982)Blutt 44, 71–78.